Mining human microbiomes reveals an untapped source of peptide antibiotics

Cell. 2024 Sep 19;187(19):5453-5467.e15. doi: 10.1016/j.cell.2024.07.027. Epub 2024 Aug 19.

Abstract

Drug-resistant bacteria are outpacing traditional antibiotic discovery efforts. Here, we computationally screened 444,054 previously reported putative small protein families from 1,773 human metagenomes for antimicrobial properties, identifying 323 candidates encoded in small open reading frames (smORFs). To test our computational predictions, 78 peptides were synthesized and screened for antimicrobial activity in vitro, with 70.5% displaying antimicrobial activity. As these compounds were different compared with previously reported antimicrobial peptides, we termed them smORF-encoded peptides (SEPs). SEPs killed bacteria by targeting their membrane, synergizing with each other, and modulating gut commensals, indicating a potential role in reconfiguring microbiome communities in addition to counteracting pathogens. The lead candidates were anti-infective in both murine skin abscess and deep thigh infection models. Notably, prevotellin-2 from Prevotella copri presented activity comparable to the commonly used antibiotic polymyxin B. Our report supports the existence of hundreds of antimicrobials in the human microbiome amenable to clinical translation.

Keywords: SEPs; antibiotics; antimicrobial peptides; computational mining; human microbiome; microproteins; peptides; smORF-encoded peptides.

MeSH terms

  • Animals
  • Anti-Bacterial Agents* / pharmacology
  • Antimicrobial Peptides* / chemistry
  • Antimicrobial Peptides* / pharmacology
  • Bacteria / classification
  • Bacteria / drug effects
  • Bacteria / genetics
  • Female
  • Humans
  • Metagenome
  • Mice
  • Microbiota* / drug effects
  • Open Reading Frames
  • Prevotella / drug effects

Substances

  • Anti-Bacterial Agents
  • Antimicrobial Peptides